{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T02:32:21Z","timestamp":1770517941138,"version":"3.49.0"},"reference-count":68,"publisher":"Japanese Society for the Study of Xenobiotics","issue":"2","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2007]]},"DOI":"10.2133\/dmpk.22.88","type":"journal-article","created":{"date-parts":[[2007,5,10]],"date-time":"2007-05-10T05:48:23Z","timestamp":1178776103000},"page":"88-95","source":"Crossref","is-referenced-by-count":28,"title":["Pharmacokinetic and Pharmacodynamic Efficacy of Intrapulmonary Administration of Ciprofloxacin for the Treatment of Respiratory Infections"],"prefix":"10.2133","volume":"22","author":[{"given":"Sumio","family":"Chono","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoharu","family":"Tanino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinobu","family":"Seki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"900","reference":[{"key":"10.2133\/dmpk.22.88_bb0005","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0092-8674(00)80754-0","article-title":"A coat protein on phagosomes involved in the intracellular survival of mycobacteria","volume":"14","author":"Ferrari","year":"1999","journal-title":"Cell"},{"key":"10.2133\/dmpk.22.88_bb0010","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1128\/CMR.17.2.413-433.2004","article-title":"Microorganisms resistant to free-living amoebae","volume":"17","author":"Greub","year":"2004","journal-title":"Clin. Microbiol. Rev."},{"key":"10.2133\/dmpk.22.88_bb0015","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1462-2920.2000.00112.x","article-title":"Abu and Kwaik, Y.: From protozoa to mammalian cells: a new paradigm in the life cycle of intracellular bacterial pathogens","volume":"2","author":"Harb","year":"2000","journal-title":"Environ Microbiol."},{"key":"10.2133\/dmpk.22.88_bb0020","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/35021074","article-title":"Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase","volume":"406","author":"McKinney","year":"2000","journal-title":"Nature"},{"key":"10.2133\/dmpk.22.88_bb0025","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1128\/IAI.60.4.1263-1267.1992","article-title":"Molecular determinants of Listeria monocytogenes pathogenesis","volume":"60","author":"Portnoy","year":"1992","journal-title":"Infect. Immun."},{"key":"10.2133\/dmpk.22.88_bb0030","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/CMR.14.3.584-640.2001","article-title":"Listeria pathogenesis and molecular virulence determinants","volume":"14","author":"Vazquez-Boland","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"10.2133\/dmpk.22.88_bb0035","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/clinids\/2.5.817","article-title":"Phagocyte strategy vs. microbial tactics","volume":"2","author":"Densen","year":"1980","journal-title":"Rev. Infect. Dis."},{"key":"10.2133\/dmpk.22.88_bb0040","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1172\/JCI109663","article-title":"Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes","volume":"65","author":"Horwitz","year":"1980","journal-title":"J. Clin. Invest."},{"key":"10.2133\/dmpk.22.88_bb0045","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1128\/IAI.56.12.3173-3179.1988","article-title":"Resistance of mucoid Pseudomonas aeruginosa to nonopsonic phagocytosis by alveolar macrophages in vitro","volume":"56","author":"Krieg","year":"1988","journal-title":"Infect. Immun."},{"key":"10.2133\/dmpk.22.88_bb0050","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1128\/IAI.15.3.760-764.1977","article-title":"Effect of protein A on staphylococcal opsonization","volume":"15","author":"Peterson","year":"1977","journal-title":"Infect. Immun."},{"key":"10.2133\/dmpk.22.88_bb0055","first-page":"247","article-title":"Inhibition of polymorphonuclear leukocyte chemotaxis by the mucoid exopolysaccharide of Pseudomonas aeruginosa","volume":"11","author":"Stiver","year":"1988","journal-title":"Clin. Invest. Med."},{"key":"10.2133\/dmpk.22.88_bb0060","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1586\/14760584.4.6.819","article-title":"Prevention of Haemophilus influenzae type b disease: past success and future challenges","volume":"4","author":"Chandran","year":"2005","journal-title":"Expert Rev. Vaccines."},{"key":"10.2133\/dmpk.22.88_bb0065","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0928-8244(02)00467-4","article-title":"Listeriosis: clinical presentation","volume":"35","author":"Doganay","year":"2003","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.2133\/dmpk.22.88_bb0070","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1093\/infdis\/163.6.1326","article-title":"Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution","volume":"163","author":"Ellner","year":"1991","journal-title":"J. Infect. Dis."},{"key":"10.2133\/dmpk.22.88_bb0075","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(03)14333-4","article-title":"Tuberculosis","volume":"362","author":"Frieden","year":"2003","journal-title":"Lancet"},{"key":"10.2133\/dmpk.22.88_bb0080","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.medmal.2005.10.007","article-title":"Targeting mechanisms of Pseudomonas aeruginosa pathogenesis","volume":"36","author":"Kipnis","year":"2006","journal-title":"Med. Mal. Infect."},{"key":"10.2133\/dmpk.22.88_bb0085","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1099\/jmm.0.45592-0","article-title":"Legionella-induced acute lung injury in the setting of hyperoxia: protective role of tumour necrosis factor-alpha","volume":"53","author":"Nara","year":"2004","journal-title":"J. Med. Microbiol."},{"key":"10.2133\/dmpk.22.88_bb0090","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ccm.2004.10.003","article-title":"Preventing pneumonia: the role for pneumococcal and influenza vaccines","volume":"26","author":"Shorr","year":"2005","journal-title":"Clin. Chest Med."},{"key":"10.2133\/dmpk.22.88_bb0095","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1183\/09031936.03.00088903","article-title":"Tularaemia","volume":"21","author":"Tarnvik","year":"2003","journal-title":"Eur. Respir. J."},{"key":"10.2133\/dmpk.22.88_bb0100","first-page":"117","article-title":"Chlamydial pneumonia in children requiring hospitalization: effect of mixed infection on clinical outcome","volume":"38","author":"Tsai","year":"2005","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.2133\/dmpk.22.88_bb0105","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1164\/rccm.200206-626OC","article-title":"Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis","volume":"167","author":"Yee","year":"2003","journal-title":"Am. J. Respir. Crit. Care. Med."},{"key":"10.2133\/dmpk.22.88_bb0110","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1128\/AAC.41.2.471","article-title":"Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: selective targeting of gyrase or topoisomerase IV by quinolones","volume":"41","author":"Pan","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.2133\/dmpk.22.88_bb0115","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/jac\/dkg255","article-title":"Stretching the mutant prevention concentration (MPC) beyond its limits","volume":"51","author":"Smith","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.2133\/dmpk.22.88_bb0120","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1128\/AAC.47.12.3935-3941.2003","article-title":"Pharmacodynamics of the new des-f(6)-quinolone garenoxacin in a murine thigh infection model","volume":"47","author":"Andes","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.2133\/dmpk.22.88_bb0125","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/jac\/45.suppl_3.41","article-title":"Comparative in vitro activity and post-antibiotic effect of gemifloxacin against Legionella spp","volume":"45","author":"Dubois","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.2133\/dmpk.22.88_bb0130","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/jac\/dkh180","article-title":"Comparative study of the in vitro activity of a new fluoroquinolone, ABT-492","volume":"53","author":"Harnett","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"10.2133\/dmpk.22.88_bb0135","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/jac\/46.2.287","article-title":"In vitro antibiotic susceptibility of Francisella tularensis isolated from humans and animals","volume":"46","author":"Ikaheimo","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.2133\/dmpk.22.88_bb0140","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/jac\/47.4.447","article-title":"Inhibitory activity of quinolones against DNA gyrase of Mycobacterium tuberculosis","volume":"47","author":"Onodera","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"10.2133\/dmpk.22.88_bb0145","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1128\/AAC.47.12.3750-3759.2003","article-title":"In vitro and in vivo antibacterial activities of DK-507k, a novel fluoroquinolone","volume":"47","author":"Otani","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.2133\/dmpk.22.88_bb0150","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1128\/AAC.47.12.3699-3703.2003","article-title":"In vivo efficacy of a new quinolone, DQ-113, against Streptococcus pneumoniae in a mouse model","volume":"47","author":"Otsu","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.2133\/dmpk.22.88_bb0155","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1128\/JCM.41.1.483-485.2003","article-title":"Antimicrobial activities against 84 Listeria monocytogenes isolates from patients with systemic listeriosis at a comprehensive cancer center (1955\u20131997)\u201d","volume":"41","author":"Safdar","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"10.2133\/dmpk.22.88_bb0160","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1128\/AAC.43.5.1077","article-title":"In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone\u201d","volume":"43","author":"Takahata","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.2133\/dmpk.22.88_bb0165","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1592\/phco.2005.25.10.1303","article-title":"A restrospextive, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone","volume":"25","author":"Mohr","year":"2005","journal-title":"Phamacotherapy"},{"key":"10.2133\/dmpk.22.88_bb0170","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0014-2999(00)00694-4","article-title":"Effect of sparfloxacin, grepafloxacin, moxifloxacin, and ciprofloxacin on cardiac action potential duration","volume":"406","author":"Patmore","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.2133\/dmpk.22.88_bb0175","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1093\/ndt\/13.10.2712","article-title":"Confusion and general seizures following ciprofloxacin administration","volume":"13","author":"Tattevin","year":"1998","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.2133\/dmpk.22.88_bb0180","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1016\/0006-2952(91)90405-T","article-title":"Accumulation of amiodarone and desethylamiodarone by rat alveolar macrophages in cell culture","volume":"42","author":"Antonini","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"10.2133\/dmpk.22.88_bb0185","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1152\/jappl.1986.60.2.532","article-title":"Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution","volume":"60","author":"Rennard","year":"1986","journal-title":"J. Appl. Physiol."},{"key":"10.2133\/dmpk.22.88_bb0190","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/jac\/26.4.503","article-title":"Uptake of clarithromycin by rat lung cells\u201d","volume":"26","author":"Kohno","year":"1990","journal-title":"J. Antimicrob Chemother."},{"key":"10.2133\/dmpk.22.88_bb0195","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Branford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.2133\/dmpk.22.88_bb0200","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1128\/AAC.31.7.1054","article-title":"Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance","volume":"31","author":"Blaser","year":"1987","journal-title":"Antimicrob. Agents. Chemother."},{"key":"10.2133\/dmpk.22.88_bb0205","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0732-8893(95)00053-D","article-title":"Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins","volume":"22","author":"Craig","year":"1995","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.2133\/dmpk.22.88_bb0210","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1128\/AAC.37.5.1073","article-title":"Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients","volume":"37","author":"Forrest","year":"1993","journal-title":"Antimicrob. Agents. Chemother."},{"key":"10.2133\/dmpk.22.88_bb0215","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00003088-199528020-00005","article-title":"The importance of pharmacokinetic\/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents\u201d","volume":"28","author":"Hyatt","year":"1995","journal-title":"Clin. Pharmacokinet."},{"key":"10.2133\/dmpk.22.88_bb0220","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/infdis\/155.1.93","article-title":"Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration","volume":"155","author":"Moore","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.2133\/dmpk.22.88_bb0225","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0034-5288(02)00039-5","article-title":"The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics","volume":"73","author":"Toutain","year":"2002","journal-title":"Res. Vet. Sci."},{"key":"10.2133\/dmpk.22.88_bb0230","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1128\/AAC.36.6.1171","article-title":"Pulmonary disposition of antimicrobial agents: methodological considerations","volume":"36","author":"Baldwin","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.2133\/dmpk.22.88_bb0235","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1165\/rcmb.2002-0180OC","article-title":"Heterogeneity of claudin expression by alveolar epithelial cells","volume":"29","author":"Wang","year":"2003","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.2133\/dmpk.22.88_bb0240","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1124\/jpet.102.042994","article-title":"Constitutive expression of p-glycoprotein in normal lung alveolar epithelium and functionality in primary alveolar epithelial cultures","volume":"304","author":"Campbell","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.2133\/dmpk.22.88_bb0245","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1073\/pnas.84.1.265","article-title":"Expression of a multidrug-resistance gene in human tumors and tissues","volume":"84","author":"Fojo","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.2133\/dmpk.22.88_bb0250","first-page":"1747","article-title":"Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines","volume":"53","author":"Zaman","year":"1993","journal-title":"Cancer Res."},{"key":"10.2133\/dmpk.22.88_bb0255","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1128\/AAC.49.6.2429-2437.2005","article-title":"Influence of efflux transporters on the accumulation and efflux of four quinolones (ciprofloxacin, levofloxacin, garenoxacin, and moxifloxacin) in J774 macrophages","volume":"49","author":"Michot","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.2133\/dmpk.22.88_bb0260","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/jac\/16.1.67","article-title":"Uptake of ciprofloxacin by human neutrophils","volume":"16","author":"Easmon","year":"1985","journal-title":"J. Antimicrob. Chemother."},{"key":"10.2133\/dmpk.22.88_bb0265","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00013542-199510000-00002","article-title":"Uptake and intracellular activity of antimicrobial agents in phagocytic cells","volume":"6","author":"Pascual","year":"1995","journal-title":"Rev. Med. Microbiol."},{"key":"10.2133\/dmpk.22.88_bb0270","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1562\/0031-8655(2001)073<0014:DBFTOT>2.0.CO;2","article-title":"Determination by fluorimetric titration of the ionization constants of ciprofloxacin in solution and in the presence of liposomes","volume":"73","author":"Vazquez","year":"2001","journal-title":"Photochem. Photobiol."},{"key":"10.2133\/dmpk.22.88_bb0275","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1128\/AAC.43.11.2710","article-title":"Mechanisms of fluoroquinolone transport by human neutrophils\u201d","volume":"43","author":"Walters","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.2133\/dmpk.22.88_bb0280","doi-asserted-by":"crossref","first-page":"48S","DOI":"10.1016\/0002-9343(92)90309-Y","article-title":"Comparative penetration of lomefloxacin and other quinolones into human phagocytes","volume":"92","author":"Perea","year":"1992","journal-title":"Am. J. Med."},{"key":"10.2133\/dmpk.22.88_bb0285","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2133\/dmpk.18.319","article-title":"Distribution characteristics of grepafloxacin, a fluoroquinolone antibiotic, in lung epithelial lining fluid and alveolar macrophage","volume":"18","author":"Deguchi","year":"2003","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.2133\/dmpk.22.88_bb0290","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ejpb.2006.04.009","article-title":"Distribution characteristics of orally administered olamufloxacin, a newly synthesized fluoroquinolone antibacterial, in lung epithelial lining fluid and alveolar macrophage in rats","volume":"64","author":"Sun","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.2133\/dmpk.22.88_bb0295","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1128\/AAC.48.7.2673-2682.2004","article-title":"Active efflux of ciprofloxacin from J774 macrophages through an MRP-like transporter","volume":"48","author":"Michot","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.2133\/dmpk.22.88_bb0300","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/019021400269952","article-title":"Asbestos stimulation triggers differential cytokine release from human monocytes and alveolar macrophages","volume":"26","author":"Geist","year":"2000","journal-title":"Exp. Lung Res."},{"key":"10.2133\/dmpk.22.88_bb0305","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1164\/ajrccm.156.1.9609140","article-title":"Expression of inducible nitric oxide synthase by macrophages in rat lung","volume":"156","author":"Liu","year":"1997","journal-title":"Am. J. Respir. Crit. Care. Med."},{"key":"10.2133\/dmpk.22.88_bb0310","first-page":"5835","article-title":"Celecoxib modulates the capacity for prostaglandin E2 and interleukin-10 production in alveolar macrophages from active smokers","volume":"9","author":"Mao","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.2133\/dmpk.22.88_bb0315","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0090-6980(88)90070-6","article-title":"The production of C3, PGE2 and TxB2 by splenic, alveolar, and peritoneal guinea pig macrophages","volume":"36","author":"Ogle","year":"1988","journal-title":"Prostaglandins"},{"key":"10.2133\/dmpk.22.88_bb0320","doi-asserted-by":"crossref","first-page":"7147","DOI":"10.1073\/pnas.78.11.7147","article-title":"Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases","volume":"78","author":"Rennard","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.2133\/dmpk.22.88_bb0325","first-page":"L660","article-title":"Surfactant protein A modulates release of reactive oxygen species from alveolar macrophages","volume":"267","author":"Weissbach","year":"1994","journal-title":"Am. J. Physiol."},{"key":"10.2133\/dmpk.22.88_bb0330","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0924-8579(02)00031-6","article-title":"Standardization of pharmacokinetic\/pharmacodynamic (PK\/PD) terminology for anti-infective drugs","volume":"19","author":"Mouton","year":"2002","journal-title":"Int. J. Antimicrob. Agents."},{"key":"10.2133\/dmpk.22.88_bb0335","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/jac\/dki079","article-title":"Standardization of pharmacokinetic\/pharmacodynamic (PK\/PD) terminology for anti-infective drugs: an update","volume":"55","author":"Mouton","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.2133\/dmpk.22.88_bb0340","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/jama.279.2.125","article-title":"Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials","volume":"279","author":"Preston","year":"1998","journal-title":"JAMA."}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1347436715302378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1347436715302378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T21:08:35Z","timestamp":1587503315000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436715302378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007]]}},"alternative-id":["S1347436715302378"],"URL":"https:\/\/doi.org\/10.2133\/dmpk.22.88","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2007]]}}}